跳至主要内容
临床试验/CTRI/2021/05/033500
CTRI/2021/05/033500已完成3 期

Effect of Intravenous Tranexamic Acid (TXA) In Addition To Active Management Of Third Stage Of Labour On Postpartum Blood Loss In Vaginal Delivery: A double Blinded , Randomized Controlled Trial - TAAPP-V Trial

AIIMS Jodhpur0 个研究点目标入组 641 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
AIIMS Jodhpur
入组人数
641

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age > 18 years
  • 2.Gestational age 34+0 weeks or more
  • 3.Singleton pregnancy
  • 4.Planned vaginal delivery
  • 5.Available venous hemogram value in week before vaginal delivery
  • 6.Signed informed consent to participate in study

排除标准

  • 1. History of venous thrombosis: deep vein thrombosis, pulmonary embolism
  • 2. History of arterial thrombosis: myocardial infarction, stroke
  • 3. Any known cardiovascular, renal, or liver disorders
  • 4. Autoimmune disease e.g. secondary APLA
  • 5. Sickle cell disease
  • 6. Severe haemorrhagic disease e.g.; VWD
  • 7. Obstetric complications - multiple pregnancy, placenta previa, abruptio placentae, Abnormal invasive placenta (placenta accrete/ increta/ percreta), Eclampsia or HELLP (haemolysis elevated liver low platelet) syndrome, in utero fetal death
  • 8.Administration of low-molecular weight heparin or antiplatelet agents in the week before delivery
  • 9. History of Epilepsy or seizure
  • 10. Active subarachnoid haemorrhage
  • 11. Colour vision disturbances
  • 12. Known hypersensitivity to tranexamic acid

研究者

发起方
AIIMS Jodhpur

相似试验

Tranexamic acid along with AMTSL for Preventing PPH... | 临床试验